Latest & greatest articles for obesity

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on obesity or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on obesity and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for obesity

61. Cost-effectiveness of incisional negative pressure wound therapy compared with standard care after caesarean section in obese women: a trial-based economic evaluation Full Text available with Trip Pro

Cost-effectiveness of incisional negative pressure wound therapy compared with standard care after caesarean section in obese women: a trial-based economic evaluation To evaluate the cost-effectiveness of incisional negative pressure wound therapy (iNPWT) in preventing surgical site infection in obese women after caesarean section.A cost-effectiveness analysis conducted alongside a clinical trial.Five obstetric departments in Denmark.Women with a pregestational body mass index (BMI) ≥30 kg/m2 (...) .We used data from a randomised controlled trial of 876 obese women who underwent elective or emergency caesarean section and were subsequently treated with iNPWT (n = 432) or a standard dressing (n = 444). Costs were estimated using data from four Danish National Databases and analysed from a healthcare perspective with a time horizon of 3 months after birth.Cost-effectiveness based on incremental cost per surgical site infection avoided and per quality-adjusted life-year (QALY) gained.The total

2019 EvidenceUpdates

62. Effects of Intermittent Versus Continuous Energy Intakes on Insulin Sensitivity and Metabolic Risk in Women with Overweight Full Text available with Trip Pro

Effects of Intermittent Versus Continuous Energy Intakes on Insulin Sensitivity and Metabolic Risk in Women with Overweight This study aimed to compare intermittent fasting (IF) versus continuous energy intakes at 100% or 70% of calculated energy requirements on insulin sensitivity, cardiometabolic risk, body weight, and composition.Women with overweight (n = 88; 50 ± 1 years, BMI 32.3 ± 0.5 kg/m2 ) were randomized to one of four diets (IF70, IF100, dietary restriction [DR70], or control (...) compared with other groups, despite modest weight loss.© 2018 The Obesity Society.

2019 EvidenceUpdates

63. Probiotics for the Prevention of Gestational Diabetes Mellitus in Overweight and Obese Women: Findings From the SPRING Double-blind Randomized Controlled Trial Full Text available with Trip Pro

Probiotics for the Prevention of Gestational Diabetes Mellitus in Overweight and Obese Women: Findings From the SPRING Double-blind Randomized Controlled Trial Given the role of gut microbiota in regulating metabolism, probiotics administered during pregnancy might prevent gestational diabetes mellitus (GDM). This question has not previously been studied in high-risk overweight and obese pregnant women. We aimed to determine whether probiotics (Lactobacillus rhamnosus and Bifidobacterium (...) animalis subspecies lactis) administered from the second trimester in overweight and obese women prevent GDM as assessed by an oral glucose tolerance test (OGTT) at 28 weeks' gestation. Secondary outcomes included maternal and neonatal complications, maternal blood pressure and BMI, and infant body composition.This was a double-blind randomized controlled trial of probiotic versus placebo in overweight and obese pregnant women in Brisbane, Australia.The study was completed in 411 women. GDM occurred

2019 EvidenceUpdates

64. Obesity in children

. Centers for Disease Control and Prevention 2000 growth charts for the United States: improvements to the 1977 National Center for Health Statistics version. Pediatrics. 2002 Jan;109(1):45-60. http://www.ncbi.nlm.nih.gov/pubmed/11773541?tool=bestpractice.com Worldwide, the definition of overweight and obesity changes; however, a BMI >85th percentile is defined as overweight or at risk for overweight in the US and UK, a BMI ≥95th percentile is variably defined as obesity or overweight, and a BMI >99th (...) percentile is defined as severe obesity. Barlow SE. Expert Committee recommendations regarding the prevention, assessment, and treatment of child and adolescent overweight and obesity: summary report. Pediatrics. 2007 Dec;120(suppl 4):S164-92. http://pediatrics.aappublications.org/content/120/Supplement_4/S164.full http://www.ncbi.nlm.nih.gov/pubmed/18055651?tool=bestpractice.com Canoy D, Bundred P. Obesity in children. BMJ Clin Evid. 2011 Apr 4;2011. pii: 0325. http://www.ncbi.nlm.nih.gov/pmc/articles

2019 BMJ Best Practice

65. Endoscopic placement and removal of an intra-gastric balloon (IGB) for the management of overweight and obesity in a high-risk patient

Endoscopic placement and removal of an intra-gastric balloon (IGB) for the management of overweight and obesity in a high-risk patient 1 Public Summary Document Application No. 1515 Endoscopic placement and removal of an intragastric balloon for the management of moderate obesity in patients with type 2 diabetes mellitus who have failed first-line treatments Applicant: Apollo Endosurgery Australia Date of MSAC consideration: MSAC 76 th Meeting, 1-2 August 2019 Context for decision: MSAC makes (...) its advice in accordance with its Terms of Reference, visit the MSAC website 1. Purpose of application An application requesting Medicare Benefits Schedule (MBS) listing of the endoscopic placement and removal of an intragastric balloon (IGB) for the treatment of patients aged = 18 years with moderate obesity (body mass index (BMI) of 30.0 to 34.9 kg/m 2 ), who have poorly controlled type 2 diabetes mellitus (T2DM) and who have failed first-line treatment options, was received from Apollo

2019 Medical Services Advisory Committee

66. Obesity, diet and nutrition evidence review technical report

and interventions are effective in preventing overweight and obesity in children? 2.1.2 Question 2 ? What universal, whole system or settings based interventions are effective in preventing overweight and obesity in adults aged 18 to 65 years? 2.2 Source identification, selection and data extraction A sensitive search was undertaken using database subject headings and wide ranging free text, keywords and synonyms. The search was limited to English language, systematic reviews and meta-analyses. 1 Baker P et al (...) undertaken by the co-reviewer. Intervention summaries were provided for specific systematic reviews, as requested by the Health Improvement team. These are available in appendix II. 3 Results Question 1: Figure 1: Flow of information through the review process for Question 1. Records excluded 48 Abstracts screened 106 Full-text articles excluded At full-text review: 28 Reasons: Overweight/obese pop n = 9 Interventions targeted or not universal/ whole systems/settings based = 8 No relevant outcomes

2019 Public Health Wales Observatory Evidence Service

67. Obesity in Wales

definition • Caveats • Data source, geography & period • Further information • ReferencesThe notes sections in this presentation include technical information relating to the corresponding slide to aid user understanding. The notes sections include the following headings: • Indicator definition • Caveats • Data source, geography & period • Further information • ReferencesIndicator definition: • Overweight or obese - The percentage of children aged 4 to 5 years who are in the 85 th centile and above (...) in children. 2011. Oxford: National Obesity Observatory. 2. Keys, A. et al Indices of relative weight and obesity. Journal of Chronic Diseases. 1972; 25:329-343.Indicator definition: • Overweight or obese - The percentage of children aged 4 to 5 years who are in the 85 th centile and above as according to the British 1990 growth reference scale (UK90) 1 • Deprivation is classified according to 2014 Welsh Index of Multiple Deprivation fifths, based on the child’s postcode of residence. • The Child

2019 Public Health Wales Observatory Evidence Service

68. [Effects of interval exercise in the improvement of glycemic control of obese adults with insulin resistance]. Full Text available with Trip Pro

[Effects of interval exercise in the improvement of glycemic control of obese adults with insulin resistance]. Background: physical exercise presents evidence for the treatment of insulin resistance. However, it is necessary to deepen this knowledge. Objective: to compare the effectiveness of a high intensity interval training program (HIIT) with one of resistance training (RT) to improve biochemical parameters of insulin/basal glycemia and post-load. Material and methods: twenty-eight (36 ± 13

2019 Nutricion hospitalaria Controlled trial quality: uncertain

69. [Teacher-Based Health Promotion in Primary School Children in Baden-Württemberg: Effects on Endurance Performance and Incidence of Abdominal Obesity]. (Abstract)

[Teacher-Based Health Promotion in Primary School Children in Baden-Württemberg: Effects on Endurance Performance and Incidence of Abdominal Obesity]. Health promotion has to start early. Many prevention programmes lack proof of effectiveness. A programme that promotes an active and healthy lifestyle for primary school children in Baden-Württemberg is "Join the Healthy Boat".The effect of this one-year school-based intervention on endurance performance and incidence of paediatric abdominal (...) obesity was investigated in a large cluster randomised study.Data of 1739 children (7.1±0.6 years) were available at baseline and follow-up. Background variables were assessed via parent questionnaires. Endurance performance (6-minute run) and anthropometric data were collected on-site. Children with waist-to-height-ratio (WHtR) ≥ 0.5 were classified as being abdominally obese. The difference in endurance capacity and the incidence of abdominal obesity between baseline and follow-up were calculated

2019 Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany)) Controlled trial quality: uncertain

70. Ethical Considerations for the Care of Patients With Obesity

to ask the patient which terms are preferred when discussing body weight (29). Although more sensitive language is recommended when speaking with the patient, medical terminology and diagnoses such as "overweight," "obese," and "morbidly obese" should still be used, as appropriate, in the medical record and for billing and coding purposes. Exhibit Empathy, Sensitivity, and Support Obstetrician–gynecologists should understand that patients with obesity may have had negative experiences with other (...) the prevalence of obesity when counseling patients concerning their weight. Many women, irrespective of demographic characteristics or income, are vulnerable to becoming overweight or obese because of limited resources for physical activity and healthy food choices, work commitments, and family demands (8). It also is important to keep in mind that many patients have already tried to lose weight, often repeatedly. Some patients may view even empathic, motivational weight-loss counseling as biased

2019 American College of Obstetricians and Gynecologists

71. Effect of metformin in addition to dietary and lifestyle advice for pregnant women who are overweight or obese: the GRoW randomised, double-blind, placebo-controlled trial (Abstract)

Effect of metformin in addition to dietary and lifestyle advice for pregnant women who are overweight or obese: the GRoW randomised, double-blind, placebo-controlled trial Maternal overweight and obesity are associated with well recognised pregnancy complications. Antenatal dietary and lifestyle interventions have a modest effect on gestational weight gain without affecting pregnancy outcomes. We aimed to assess the effects on maternal and infant outcomes of antenatal metformin given (...) in addition to dietary and lifestyle advice among overweight and obese pregnant women.GRoW was a multicentre, randomised, double-blind, placebo-controlled trial in which pregnant women at 10-20 weeks' gestation with a BMI of 25 kg/m2 or higher were recruited from three public maternity units in Adelaide, SA, Australia. Women were randomly assigned (1:1) via a computer-generated schedule to receive either metformin (to a maximum dose of 2000 mg per day) or matching placebo. Participants, their antenatal

2019 EvidenceUpdates

72. Effects of a Community-Based Diabetes Prevention Program for Latino Youth with Obesity: A Randomized Controlled Trial Full Text available with Trip Pro

Effects of a Community-Based Diabetes Prevention Program for Latino Youth with Obesity: A Randomized Controlled Trial This study examined the short- and long-term effects of a community-based lifestyle intervention among Latino youth with obesity.Latino adolescents (14-16 years old) were randomized to a 3-month lifestyle intervention (n = 67) or comparison control (n = 69) and followed for 12 months. The intervention included weekly nutrition and health classes delivered to groups of families (...) population of Latino adolescents at high risk for developing type 2 diabetes.© 2018 The Obesity Society.

2019 EvidenceUpdates

73. Obesity: Orlistat

Obesity: Orlistat Orlistat | Prescribing information | Obesity | CKS | NICE Search CKS… Menu Orlistat Obesity: Orlistat Last revised in December 2017 Orlistat What are the contraindications and cautions for orlistat? Do not prescribe orlistat to: People with chronic malabsorption syndrome or cholestasis — dietary absorption of fat is already impaired in these people. Breastfeeding women — it is not known whether orlistat is secreted into human milk. Prescribe orlistat with caution to people

2019 NICE Clinical Knowledge Summaries

74. Obesity

Obesity Obesity | Topics A to Z | CKS | NICE Search CKS… Menu Obesity Obesity Last revised in December 2017 The terms 'overweight' and 'obesity' are used to describe excess body fat. Diagnosis Management Prescribing information Background information Obesity: Summary The terms 'overweight' and 'obesity' are used to describe excess body fat. Obesity results from an imbalance between energy intake and energy expenditure. Many factors can influence this, including lifestyle, genetics, medical (...) conditions, and medication. Different weight classes are defined according to a person's body mass index (BMI). This is calculated by dividing the person's weight in kilograms by the square of their height in metres: Healthy weight — BMI of 18.5–24.9 kg/m 2 Overweight — BMI of 25–29.9 kg/m 2 Obesity l — BMI of 30–34.9 kg/m 2 Obesity ll — BMI of 35–39.9 kg/m 2 Obesity lll — BMI of 40 kg/m 2 or more Obesity is a global problem. In the UK, more than 1 in 4 adults is obese, and the prevalence is increasing

2019 NICE Clinical Knowledge Summaries

75. General medicine: Lorcaserin in obesity: minimal benefits and ill-defined harms

observed and the selective reporting of harms leave major uncertainties about lorcaserin’s benefit-harm profile . Lorcaserin has recently been hailed in news media as the new ‘holy grail’ in managing obesity. Is this true? Or are we being misled? This claim is based on the results of a study of lorcaserin in 12 000 overweight or obese subjects with high cardiovascular risk profiles. 1 The authors concluded that lorcaserin generated sustained weight loss without increased risks of major cardiovascular (...) General medicine: Lorcaserin in obesity: minimal benefits and ill-defined harms Lorcaserin in obesity: minimal benefits and ill-defined harms | BMJ Evidence-Based Medicine Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password

2019 Evidence-Based Medicine

76. Effect of weight reduction on severity of lower urinary tract symptoms in obese men with benign prostatic hyperplasia. (Abstract)

Effect of weight reduction on severity of lower urinary tract symptoms in obese men with benign prostatic hyperplasia. 29938670 2018 12 11 2018 12 11 1024-2708 23 Suppl 2 3 2017 06 Hong Kong medical journal = Xianggang yi xue za zhi Hong Kong Med J Effect of weight reduction on severity of lower urinary tract symptoms in obese men with benign prostatic hyperplasia. 35-37 Ng C F CF Division of Urology, Department of Surgery, The Chinese University of Hong Kong. Yee C H CH Division of Urology (...) Urinary Tract Symptoms drug therapy Male Middle Aged Obesity Prospective Studies Prostatic Hyperplasia drug therapy Severity of Illness Index Weight Loss 2018 6 26 6 0 2018 6 26 6 0 2018 12 12 6 0 ppublish 29938670

2018 Hong Kong medical journal = Xianggang yi xue za zhi Controlled trial quality: uncertain

77. Multicomponent Obesity Prevention Intervention in Low-Income Preschoolers: Primary and Subgroup Analyses of the NET-Works Randomized Clinical Trial, 2012-2017 Full Text available with Trip Pro

in the NET-Works group at 24 (rate ratio = 0.84; 95% CI = 0.75, 0.93) and 36 months (rate ratio = 0.88; 95% CI = 0.78, 0.99). Children with baseline overweight or obesity had lower BMI in the NET-Works group than those in usual care at 36 months (-0.71 kg/m2; 95% CI = -1.30, -0.12). Hispanic children had lower BMI in the NET-Works group than those in usual care at 36 months (-0.59 kg/m2; 95% CI = -1.14, -0.04).In secondary analyses, NET-Works significantly reduced BMI over 3 years among Hispanic children (...) Multicomponent Obesity Prevention Intervention in Low-Income Preschoolers: Primary and Subgroup Analyses of the NET-Works Randomized Clinical Trial, 2012-2017 To evaluate a multicomponent obesity prevention intervention among diverse, low-income preschoolers.Parent-child dyads (n = 534) were randomized to the Now Everybody Together for Amazing and Healthful Kids (NET-Works) intervention or usual care in Minneapolis, MN (2012-2017). The intervention consisted of home visits, parenting classes

2018 EvidenceUpdates

78. Care of Women with Obesity in Pregnancy

: a prospective controlled cohort study. Obes Facts 2013;6:152–64. 110. Claesson IM, Sydsj€ o G, Brynhildsen J, Cedergren M, Jeppsson A, Nystr€ om F, et al. Weight gain restriction for obese pregnant women: a case-control intervention study. BJOG 2008;115:44–50. 111. Dodd JM, Crowther CA, Robinson JS. Dietary and lifestyle interventions to limit weight gain during pregnancy for obese or overweight women: a systematic review. Acta Obstet Gynecol Scand 2008;87:702–6. 112. National Institute of Health and Care (...) Excellence. Antenatal and postnatal mental health: clinical management and service guidance. Clinical guideline 192. Manchester; NICE: 2014. 113. Stothard KJ, Tennant PW, Bell R, Rankin J. Maternal overweight and obesity and the risk of congenital anomalies: a systematic review and meta-analysis. JAMA 2009;301:636–50. 114. Aagaard-TilleryKM,FlintPorterT,MaloneFD,NybergDA,CollinsJ, Comstock CH, et al. In?uence of maternal BMI on genetic sonographyintheFaSTERtrial. Prenat Diagn 2010;30:14–22. 115. Gandhi M

2018 Royal College of Obstetricians and Gynaecologists

79. Intraoperative use of methadone improves control of postoperative pain in morbidly obese patients: a randomized controlled study Full Text available with Trip Pro

Intraoperative use of methadone improves control of postoperative pain in morbidly obese patients: a randomized controlled study Surgical patients still commonly experience postoperative pain. With the increasing prevalence of obesity, there is a growing demand for surgical procedures by this population. Intraoperative use of methadone has not been well assessed in this population.Patients with a body mass index of 35 kg/m2 or more undergoing bariatric surgery were randomly assigned to receive (...) -month postoperative evaluation than group M.Intraoperative methadone can safely lower postoperative opioid consumption and improve postoperative pain scores compared with fentanyl in morbidly obese patients.

2018 EvidenceUpdates Controlled trial quality: predicted high

80. Effectiveness of an App and Provider Counseling for Obesity Treatment in Primary Care Full Text available with Trip Pro

Effectiveness of an App and Provider Counseling for Obesity Treatment in Primary Care Obesity treatment is less successful for socioeconomically disadvantaged populations, particularly when delivered in primary care. Digital health strategies can extend the reach of clinical obesity treatments to care settings serving patients at highest risk.Track was an effectiveness RCT of a 12-month digital weight-loss intervention, embedded within a community health center system. Participants were 351 (...) adult patients (aged 21-65 years) with obesity and hypertension, diabetes, and hyperlipidemia. Patients were randomized to usual care (n=175) or an intervention (n=176) comprising app-based self-monitoring of behavior change goals with tailored feedback, a smart scale, dietitian-delivered counseling calls, and clinician counseling informed by app-generated recommendations, delivered via electronic health record. The primary outcome was 12-month weight change. Randomization began on June 18, 2013

2018 EvidenceUpdates